Organization · Venture Capital
Humain Ventures
Humain Ventures is an investment organization focused on the health sector, particularly in TechBio, AI, therapeutics, and biosensing. It targets early-stage companies in the United States.
Overview
What Humain Ventures does
What Humain Ventures is
Humain Ventures is an investment organization focused on the health sector, particularly in TechBio, AI, therapeutics, and biosensing. It targets early-stage companies in the United States.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2023
- Approximate age
- About 3 years
- Structured capabilities
- Funder
- Last reviewed
- April 30, 2026
Official channels
Find Humain Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Humain Ventures as a funder
Investment thesis
Humain Ventures focuses on TechBio, leveraging AI, computation, biosensing, and biotechnology to enhance healthcare and drug discovery outcomes.
Focus narrative
Humain Ventures invests in companies within the health industry, targeting various stages of development, particularly early-stage and Series A investments. The firm is particularly interested in startups that utilize AI and biotechnology to create innovative healthcare solutions.
Value beyond capital
Humain Ventures adds value to its portfolio companies by leveraging its expertise in TechBio and healthcare, providing strategic guidance, and facilitating connections within the industry to enhance growth and innovation.
Focus and fit
- Stages
- Pre-seed · Seed · Series A
- Regions
- North AmericaUnited States
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 1
Portfolio context
Unnatural Products: A TechBio company that employs AI-enhanced chemistry to design molecularly targeted therapeutics. Humain Ventures participated in their $32M Series A funding announced in December 2023.
Common questions
What to know about Humain Ventures
Upseed classifies Humain Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 30, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.